We observed a high tobacco use prevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missed opportunity to impact the high tobacco use burden in opioid-dependent persons.
We observed a high tobacco useprevalence among buprenorphine patients, and limited provision of cessation treatment. This is a missedopportunity to impact the high tobacco use burden in opioid-dependent persons.